Andrew Combs is Chief Chemistry Officer at Prelude Therapeutics Inc (PRLD). They have made 4 open-market trades across 1 company since 2020, most recently 2025-03-25.
CIK 0001825005
4 open-market purchases totalling $269K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRLD | 480,123 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2025-03-27 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.